Identification of biological markers

PreclinicalBiologic

AAssistance Publique - Hôpitaux de Paris

Identification of biological markers is one of 13 biologic programs targeting Hemophagocytic Syndrome. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hemophagocytic SyndromeActive, not recruiting

Hemophagocytic SyndromePreclinical

Active, not recruiting

Competition

Competitive Landscape

14 competitors in Hemophagocytic Syndrome

#DrugCompanyPhaseTrials

Cytoxan

BBaxter Healthcare Corporation

Rayos

Brukinsa

Jakafi

2 5

Actemra

Roche

Phase 2

—6

Oncovin

EEastern Cooperative Oncology Group

Phase 2

—7

Adriamycin

GGynecologic Oncology Group

Phase 2

—8

Etopophos

GGerman Society for Pediatric Oncology and Hematology GPOH gGmbH

Itacitinib

Tepadina

Alnylam Pharmaceuticals

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hemophagocytic Syndrome1 trial

Children and Adult Hemophagocytic Syndrome (HLHa)

Completed·AAssistance Publique - Hôpitaux de Paris··NCT02113917·204 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Identification of biological markers. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Identification of biological markers compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Identification of biological markers. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

Identification of biological markers

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hemophagocytic Syndrome1 trial

References

Drug Info

Quick Facts

Related News